Product Information
RUFINAMIDE 400 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $1.3904 per EA under NDC 42571039212. Its NADAC has been published 131 times since Dec 27, 2023.
Strength
400 mg/1
Manufacturer
Micro Labs LimitedNDC
42571039212
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216688On Market Since
7/1/2023
Price Statistics
The NADAC for RUFINAMIDE 400 MG TABLET has been published 131 times since Dec 27, 2023, and over the history we have for it it has declined 61.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3904 per EA |
|---|---|
| All-time high | $3.9520 (Feb 14, 2024) |
| All-time low | $1.3608 (May 20, 2026) |
| 52-week high | $1.7050 |
| 52-week low | $1.3608 |
| Median price | $1.8124 |
| Average price | $2.1344 |
| Largest weekly change | -38.3% (May 22, 2024) |
| Weeks tracked | 131 |
| Tracking since | Dec 27, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the RUFINAMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RUFINAMIDE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 400 MG TABLET, manufactured by Micro Labs Limited, is $1.3904 per EA (NDC 42571039212), effective Jun 24, 2026.
How has the price of RUFINAMIDE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 400 MG TABLET has declined 61.8%. It has been tracked across 131 weekly CMS publications since Dec 27, 2023.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 400 MG TABLET?
Since Dec 27, 2023, the NADAC for RUFINAMIDE 400 MG TABLET has ranged from a low of $1.3608 (May 20, 2026) to a high of $3.9520 (Feb 14, 2024), with a median of $1.8124 per EA.
Are there cheaper alternatives to RUFINAMIDE 400 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RUFINAMIDE 400 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures RUFINAMIDE 400 MG TABLET?
RUFINAMIDE 400 MG TABLET (NDC 42571039212) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification